B Lymphocytes Are Critical for Lung Fibrosis Control and Prostaglandin E2 Regulation in IL-9 Transgenic Mice
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We previously showed that overexpression of IL-9 controls lung fibrosis induced by silica particles in mice (Arras and colleagues; Am J Respir Cell Mol Biol 2001;24:368–375). This protection was associated with an expansion of lung B lymphocytes. To explore the contribution of these cells in the protective effect of IL-9, we crossed IL-9 transgenic (IL-9+) and B-deficient (B−) mice. The antifibrotic effect of IL-9 was abolished in mice deficient in B lymphocytes (B−IL-9+) and restored by reconstituting these mice with B lymphocytes. The expression of the antifibrotic mediator prostaglandin (PG)E2 was markedly increased in the lung of IL-9+ mice at baseline, and similarly high levels were found in both wild-type and transgenic strains upon silica treatment. This PGE2 expression was completely abolished in B− mice, both at baseline and upon silica administration. In vitro, alveolar and peritoneal macrophages from IL-9+ mice had an increased capacity to produce PGE2 in response to LPS or silica. This capacity was markedly reduced in macrophages obtained from B− mice and restored by co-incubating macrophages with B lymphocytes from IL-9+ mice. The increased PGE2 response of IL-9+ macrophages was dependent on cyclooxygenase 2 expression, based on transcript analysis and inhibition by NS398. We conclude that B lymphocytes are essential for the protection against lung fibrosis and macrophage overexpression of PGE2 in IL-9 transgenic animals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“data gleaned in other models show that B cells may actually suppress fibrotic response (171)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [171]
Citations
Cites
Kitamura, D., Roes, J., Kühn, R., & Rajewsky, K. (1991) · Nature · doi:10.1038/350423a0 · Cited by 1,783
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury
Sibille, Y., & Reynolds, H. Y. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.471 · Cited by 1,083 · cited 1×
“This observation suggests that, in the lung, IL-9 modulates an early process involved in the physiologic differentiation of alveolar macrophages (induced, for example, by oxygen or surfactant components [32], or by airway antigens [33]).”
BackgroundLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725
Temann, U.-A., Geba, G. P., Rankin, J. A., & Flavell, R. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1307 · Cited by 452
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling
Holgate, S. T., Peters-Golden, M., Panettieri, R. A., & Henderson, W. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.25 · Cited by 318
Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.
Thrall, R. S., McCormick, J. R., Jack, R., McReynolds, R. A., & Ward, P. A. (1979) · PubMed Central · Cited by 303
Uyttenhove, C., Simpson, R. J., & Van Snick, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6934 · Cited by 299
Interleukin-9 Upregulates Mucus Expression in the Airways
Louahed, J., Toda, M., Jen, J., Hamid, Q., Renauld, J.-C., Levitt, R. C., & Nicolaides, N. C. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.6.3927 · Cited by 277
Self-citationPulmonary fibrosis: cytokines in the balance
Coker, R., & Laurent, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11061218 · Cited by 267
Rom, W. N., Bitterman, P. B., Rennard, S. I., Cantin, A., & Crystal, R. G. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1429 · Cited by 257
Keerthisingam, C. B., Jenkins, R. G., Harrison, N. K., Hernandez-Rodriguez, N. A., Booth, H., Laurent, G. J., Hart, S. L., Foster, M. L., & McAnulty, R. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64092-8 · Cited by 241
Dual Roles of IL-4 in Lung Injury and Fibrosis
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., & Phan, S. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2083 · Cited by 236
Self-citationSaito, E., Fujimoto, M., Hasegawa, M., Komura, K., Hamaguchi, Y., Kaburagi, Y., Nagaoka, T., Takehara, K., Tedder, T. F., & Sato, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15078 · Cited by 225
Saito, E., Fujimoto, M., Hasegawa, M., Komura, K., Hamaguchi, Y., Kaburagi, Y., Nagaoka, T., Takehara, K., Tedder, T. F., & Sato, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215078 · Cited by 210
Whittaker, L., Niu, N., Temann, U.-A., Stoddard, A., Flavell, R. A., Ray, A., Homer, R. J., & Cohn, L. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4838 · Cited by 188
B-lymphocytes, innate immunity, and autoimmunity
Viau, M., & Zouali, M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.08.019 · Cited by 183
Thymic lymphomas in interleukin 9 transgenic mice.
Renauld, J., van der Lugt, N. M. T., Vink, A., van ROON, M. A., Godfraind, C., Warnier, G., Merz, H., Feller, A. C., Berns, A. J. M., & SNICK, J. V. (1994) · PubMed · Cited by 134
Self-citationInterleukin 9–induced In Vivo Expansion of the B-1 Lymphocyte Population
Vink, A., Warnier, G., Brombacher, F., & Renauld, J.-C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1413 · Cited by 129
Self-citationTcgfiii/p40 is produced by naive murine cd4+ t cells but is not a general t cell growth factor*
Schmitt, E., Brandwijk, R. V., Snick, J. V., Siebold, B., & Rüde, E. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191130 · Cited by 115
Susceptibility of Cyclooxygenase-2-Deficient Mice to Pulmonary Fibrogenesis
Bonner, J. C., Rice, A. B., Ingram, J. L., Moomaw, C. R., Nyska, A., Bradbury, A., Sessoms, A. R., Chulada, P. C., Morgan, D. L., Zeldin, D. C., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64202-2 · Cited by 113
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process.
Elias, J. A., Rossman, M. D., Zurier, R. B., & Daniele, R. P. (1985) · PubMed · doi:10.1164/arrd.1985.131.1.94 · Cited by 107
Arras, M., Huaux, F., Vink, A., Delos, M., Coutelier, J.-P., Many, M.-C., Barbarin, V., Renauld, J.-C., & Lison, D. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.4249 · Cited by 102
Self-citationFormation of Prostaglandins E2 and D2 via the Isoprostane Pathway
Gao, L., Zackert, W. E., Hasford, J. J., Danekis, M. E., Milne, G. L., Remmert, C., Reese, J., Yin, H., Tai, H., Dey, S. K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303984200 · Cited by 94
Hasegawa, M., Fujimoto, M., Takehara, K., & Sato, S. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.03.013 · Cited by 92
Clark, J. G., Kostal, K. M., & Marino, B. A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34302-3 · Cited by 91
Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T. H., Simon, R. H., Nakamura, T., & Miyake, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63196-3 · Cited by 81 · cited 1×
“In this strain, the absence of B lymphocytes per se (30) and/or the contribution of other antifibrotic mediators (e.g., HGF [ 31 ]), deserves further investigations.”
BackgroundPeebles, R. S., Dworski, R., Collins, R. D., Jarzecka, K., Mitchell, D. B., Graham, B. S., & Sheller, J. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9911063 · Cited by 79
Kuroda, E., Sugiura, T., Okada, K., Zeki, K., & Yamashita, U. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1650 · Cited by 72
Tumanov, A. V., Kuprash, D. V., Mach, J. A., Nedospasov, S. A., & Chervonsky, A. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.86 · Cited by 69
Grohmann, U., Snick, J. V., Campanile, F., Silla, S., Giampietri, A., Vacca, C., Renauld, J., Fioretti, M. C., & Puccetti, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4197 · Cited by 69
Self-citationGarrone, P., Galibert, L., Rousset, F., Fu, S. M., & Banchereau, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4282 · Cited by 67
Kumar, R. K. (1989) · Europe PMC (PubMed Central) · Cited by 56
Ferru, Roye, Delacre, Auriault, & Wolowczuk (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00376.x · Cited by 50
Knoops, L., Louahed, J., & Renauld, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6101 · Cited by 36
Self-citationBiondi, P. A., Chiesa, L. M., Storelli, M. R., & Renon, P. (1997) · Journal of Chromatographic Science · doi:10.1093/chromsci/35.11.509 · Cited by 36
Friedetzky, A., Garn, H., Kirchner, A., & Gemsa, D. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80068-5 · Cited by 35
Pilette, C., Ouadrhiri, Y., Snick, J. V., Renauld, J., Staquet, P., Vaerman, J., & Sibille, Y. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00005402 · Cited by 32
Self-citationEnhanced Release of Prostaglandin E2 from Macrophages of Rats with Silicosis
Mohr, C., Davis, G. S., Graebner, C., Hemenway, D. R., & Gemsa, D. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/6.4.390 · Cited by 31
IL-9 Protects against Bleomycin-Induced Lung Injury
Arras, M., Louahed, J., Heilier, J.-F., Delos, M., Brombacher, F., Renauld, J., Lison, D., & Huaux, F. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62236-5 · Cited by 30
Self-citationIL-9 and Lung Fibrosis: A Th2 Good Guy?
Hoyle, G. W., & Brody, A. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.f205 · Cited by 19
Human Alveolar Macrophage Inhibition of Lung Fibroblast Growth
Elias, J. A., Rossman, M. D., Zurier, R. B., & Daniele, R. P. (2015) · American Review of Respiratory Disease · Cited by 13
Monocytes incubated with surfactant: a model for human alveolar macrophages?
Geertsma, M. F., van Furth, R., & Nibbering, P. H. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.4.485 · Cited by 12 · cited 1×
“This observation suggests that, in the lung, IL-9 modulates an early process involved in the physiologic differentiation of alveolar macrophages (induced, for example, by oxygen or surfactant components [32], or by airway antigens [33]).”
BackgroundTarter, T. H., Cunningham–Rundles, S., Laurence, J., & KOIDE, S. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.4321 · Cited by 8
Hui, R., & Falardeau, P. (1990) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(90)90058-s · Cited by 5
(2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)70109-2 · Cited by 5
Interleukin-One Induced Arachidonic Acid Turnover in Macrophages
Watson, J. A., & Wijelath, E. S. (1990) · Autoimmunity · doi:10.3109/08916939008998435 · Cited by 3
Research works printed but not linked: 6
- 1994, Oncogene, 9, 1327
- 1985, Am Rev Respir Dis, 131, 94
- 1979, Am J Pathol, 95, 117
- 2005, J Dermatol Sci, 39, 1
- 2002, Nat Immunol, 3, 944
- 1989, Am J Pathol, 135, 605
Cited by
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“The presence of B cells was necessary for the protective effect of IL-9, demonstrated by lack of reduction in fibrosis in B cell-deficient mice, and by a restoration of the reduction in fibrosis by B cell reconstitution [178].”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“However, because data gleaned in other models show that B cells may actually suppress fibrotic response (171), precise understanding of the relationship between B cells and IPF remains elusive and the potential contribution these cells to IPF pathogenesis remains a query in need of further study.”
ResultRole of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 219
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 182
New developments in the understanding of immunology in silicosis
Huaux, F. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32802bf8a5 · Cited by 175
Self-citation
Metadata
- Authors
- Arras, M., Louahed, J., Simoen, V., Barbarin, V., Misson, P., van den Brûle, S., Delos, M., Knoops, L., Renauld, J.-C., Lison, D., & Huaux, F.
- Affiliations
- Ludwig Cancer Research (BE)
- Unit of Industrial Toxicology and Occupational Medicine, Unit of Experimental Medicine and Ludwig Institute for Cancer Research, Faculty of Medicine, and Laboratory of Pathology, University Hospital of Mont-Godinne, Yvoir, Université catholique de Louvain, Brussels, Belgium
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-01
- Volume
- 34
- Issue
- 5
- Pages
- 573-580
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2165549059
- Cited by
- 46
- References
- 50
- Citations by year
- 2024: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 1 · 2012: 2
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- IL-9, pulmonary fibrosis, B cells, prostaglandin E2, macrophages, cyclooxygenase-2, silica-induced fibrosis, B cell deficiency
- MeSH terms
- Prostaglandin-E Synthases, Animals, B-Lymphocytes, Bronchoalveolar Lavage Fluid, Collagen, Female, Gene Expression Regulation, Lung, Mice, Transgenic, Pulmonary Fibrosis, Silicon Dioxide, Subcellular Fractions, Dinoprostone, Macrophages, Alveolar, Interleukin-9, Macrophages, Peritoneal, Intramolecular Oxidoreductases, Mice, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.